DrugMEt Pharmacogenetics Product Achieves CE Mark for IVD Use

KUOPIO, Finland, and SAN DIEGO, May 2 /PRNewswire-FirstCall/ — Jurilab, a privately-held Finnish biotechnology company, and Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that the European CE Mark for IVD (in vitro diagnostic) use has been achieved for the DrugMEt(R) pharmacogenetic test.

Source: Nanogen